Learn how tirzepatide’s dual GIP/GLP‑1 “twincretin” mechanism outperforms classic GLP‑1 drugs like semaglutide, delivering deeper weight loss, better glycemic control, and convenient once‑weekly dosing for type 2 diabetes and obesity.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs